EUVIMEDEUVIMED entdecken
Multizentrische Studie

Fresh frozen plasma, fibrinogen concentrate, and antithrombin concentrate administration for obstetrical disseminated intravascular coagulation by the Japanese previous and new criteria

Mamoru Morikawa iD, Shigetaka Matsunaga iD, Shintaro Makino iD, Yoshiharu Takeda, Hironobu Hyodo iD, Masafumi Nii iD, Mariko Serizawa, Eriko Eto, Jun Takeda iD, Tomoko Adachi, Takao Kobayashi iD, Atsuo Itakura iD

Journal of Obstetrics and Gynaecology Research · 2025-02 · 51 (2)

DOI: 10.1111/jog.16220 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Journal of Obstetrics and Gynaecology Research, online erschienen am 29.01.2025. Verfasst von Mamoru Morikawa und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynecology, Kansai Medical University, Hirakata, Osaka, Japan. Hauptthemen laut MEDLINE: Disseminated Intravascular Coagulation, Fibrinogen, Antithrombins, Plasma. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 18 Literaturangaben. Gefördert von: Japan Blood Products Organization.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aim

The purpose of this study is to clarify the frequencies of fresh frozen plasma (FFP) ± fibrinogen concentrate administration (fibrinogen concentrate [FC] therapy) and antithrombin (AT) concentrate administration (AT therapy) for the women with obstetrical disseminated intravascular coagulation (DIC).

Methods

Two retrospective multicenter case–control studies as Study‐1 (January–December 2018) and Study‐2 (July 2022–June 2023) were conducted. Study‐1 was the historical control of Study‐2. All participants experienced a blood loss of ≥1000 mL during vaginal delivery or ≥2000 mL during cesarean section. All participants were subsequently assigned to the DIC group or non‐DIC group.

Results

Study‐1 comprised 175 women (obstetrical DIC, 27; control, 148; by the previous criteria) and Study‐2 comprised 175 women (obstetrical DIC, 9; control, 166; by the new criteria). The frequencies of FFP (±FC therapy) or FC therapy in DIC group were significantly higher than non‐DIC group in Study‐1 (88.9% vs. 25.0%, 44.4% vs. 4.0%) and Study‐2 (100% vs. 24.7%, 77.8% vs. 5.4%); however, the frequencies of AT therapy were similar. Furthermore, in the DIC group, all women with fibrinogen

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Disseminated Intravascular CoagulationFibrinogenAntithrombinsPlasmaPregnancy Complications, HematologicHumansFemalePregnancyRetrospective StudiesAdultCase-Control StudiesJapanEast Asian People

Stichwörter der Autor:innen

antithrombin concentratefibrinogen concentratefresh frozen plasmaobstetrical disseminated intravascular coagulationpostpartum hemorrhage

Substanzen

FibrinogenAntithrombins

Autor:innen und Institutionen

  • Department of Obstetrics and Gynecology, Kansai Medical University, Hirakata, Osaka, Japan.
  • Department of Obstetrics and Gynecology, Hokkaido University Graduate School of Medicine, Sapporo, Japan.
  • Department of Obstetrics and Gynecology, Center for Maternal, Fetal, and Neonatal Medicine, Saitama Medical Center, Saitama Medical University, Kawagoe, Saitama, Japan.
  • Department of Obstetrics and Gynecology, Juntendo University Urayasu Hospital, Urayasu, Chiba, Japan.
  • Department of Obstetrics and Gynecology, Aiiku Maternal and Child Health Center, Aiiku Hospital, Tokyo, Japan.
  • Department of Obstetrics and Gynecology, Tokyo Metropolitan Bokutoh Hospital, Tokyo, Japan.

ORCID-Profile: Mamoru Morikawa, Shigetaka Matsunaga, Shintaro Makino, Hironobu Hyodo, Masafumi Nii, Jun Takeda, Takao Kobayashi, Atsuo Itakura

Förderung

  • Japan Blood Products Organization

Zitieren

APA

Morikawa, M., Matsunaga, S., Makino, S., Takeda, Y., Hyodo, H., Nii, M., Serizawa, M., Eto, E., Takeda, J., Adachi, T., Kobayashi, T., & Itakura, A. (2025). Fresh frozen plasma, fibrinogen concentrate, and antithrombin concentrate administration for obstetrical disseminated intravascular coagulation by the Japanese previous and new criteria. Journal of Obstetrics and Gynaecology Research, 51(2). https://doi.org/10.1111/jog.16220

Vancouver

Morikawa M, Matsunaga S, Makino S, Takeda Y, Hyodo H, Nii M, et al. Fresh frozen plasma, fibrinogen concentrate, and antithrombin concentrate administration for obstetrical disseminated intravascular coagulation by the Japanese previous and new criteria. Journal of Obstetrics and Gynaecology Research. 2025;51(2). doi:10.1111/jog.16220

BibTeX
@article{Morikawa2025,
  author = {Morikawa, Mamoru and Matsunaga, Shigetaka and Makino, Shintaro and Takeda, Yoshiharu and Hyodo, Hironobu and Nii, Masafumi and Serizawa, Mariko and Eto, Eriko and Takeda, Jun and Adachi, Tomoko and Kobayashi, Takao and Itakura, Atsuo},
  title = {Fresh frozen plasma, fibrinogen concentrate, and antithrombin concentrate administration for obstetrical disseminated intravascular coagulation by the Japanese previous and new criteria},
  journal = {Journal of Obstetrics and Gynaecology Research},
  year = {2025},
  volume = {51},
  number = {2},
  doi = {10.1111/jog.16220}
}
Kostenlos starten →